Diamyd Medical AB (publ) (DMYD-B) — Capital Reinvestment Ratio
Diamyd Medical AB (publ) (DMYD-B) has a Capital Reinvestment Ratio of 2026.00x as of November 2021, meaning it reinvests 2026% of its operating cash flow (Skr21.00K) in capital expenditures (Skr42.55 Million). Check Diamyd Medical AB (publ) tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Diamyd Medical AB (publ) Capital Reinvestment Ratio (2010–2020)
This chart tracks Diamyd Medical AB (publ)'s Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see Diamyd Medical AB (publ) (DMYD-B) cash flow conversion.
Annual Capital Reinvestment Ratio for Diamyd Medical AB (publ) (2010–2020)
Year-by-year Capital Reinvestment Ratio for Diamyd Medical AB (publ) from 2010 to 2020. See Diamyd Medical AB (publ) free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.12x | Skr16.88 Million | Skr1.98 Million | ▲ +3681.4% |
| 2010 | 0.00x | Skr225.77 Million | Skr700.00K | — |